Cargando…

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis

AIMS: Persistent hepatic necroinflammatory damage almost always results in fibrosis/cirrhosis or even hepatocellular carcinoma. Therefore, the presence of active necroinflammation in the liver suggests that nonalcoholic fatty liver disease (NAFLD) patients are in urgent need of treatment. Unfortunat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Leijie, Yao, Mingjie, Liu, Shuhong, Yang, Danli, Wen, Xiajie, Ning, Jing, Wang, Lu, Zhou, Guangde, Xu, Qiang, Chen, Xiangmei, Zhao, Jingmin, Lu, Fengmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024097/ https://www.ncbi.nlm.nih.gov/pubmed/32089754 http://dx.doi.org/10.1155/2020/6036904

Ejemplares similares

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
por: Qian, Xiangjun, et al.
Publicado: (2019)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
por: Tong, Jingjing, et al.
Publicado: (2022)

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study
por: Wang, Leijie, et al.
Publicado: (2019)

Use of serum Golgi protein 73 for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community
por: Duan, Jinwei, et al.
Publicado: (2022)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021)

Death and fire—the concept of necroinflammation
por: Linkermann, Andreas
Publicado: (2018)

Serum HBV RNA is a Potential Predictor of Hepatitis B Surface Antigen Reversion
por: Wang, Jie, et al.
Publicado: (2018)

Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery
por: Wen, Xiajie, et al.
Publicado: (2018)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
por: Yalniz, Mehmet, et al.
Publicado: (2006)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B
por: Ren, Yan, et al.
Publicado: (2022)

Neonatal obstructive nephropathy induces necroptosis and necroinflammation
por: Popper, Bastian, et al.
Publicado: (2019)

Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Ramachandran, Prasanna, et al.
Publicado: (2022)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection
por: Yan, Ying, et al.
Publicado: (2019)

Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
por: Yao, Mingjie, et al.
Publicado: (2016)

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
por: Bihrer, Verena, et al.
Publicado: (2011)

Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B
por: Wu, Rui, et al.
Publicado: (2018)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer
por: Xu, Zheng-Ju, et al.
Publicado: (2022)

Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models
por: Chiappini, Franck, et al.
Publicado: (2016)

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
por: Tomar, Bhawna, et al.
Publicado: (2020)

Types of necroinflammation, the effect of cell death modalities on sterile inflammation
por: Mázló, Anett, et al.
Publicado: (2022)

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
por: Xu, Gang, et al.
Publicado: (2021)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
por: Wang, Yanan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u01lks5q7m2ogga4j5ftu1tlr3